Pacquiao to pay $5M fine if he fails drug test for Mayweather bout | Inquirer Sports

Pacquiao to pay $5M fine if he fails drug test for Mayweather bout

/ 08:32 PM February 16, 2015

Manny Pacquiao AP FILE PHOTO

Manny Pacquiao AP FILE PHOTO

MANILA, Philippines – Welterweight boxing champion Manny Pacquiao said he is willing to pay a $5 million fine if he fails the drug test for the anticipated bout with flamboyant American boxer Floyd Mayweather.

Making a rare appearance in the House of Representatives on Monday, the boxing champion cum Sarangani congressman said he was the one who proposed that provision in the fight contract with Mayweather.

Article continues after this advertisement

“Hindi problema yun. Ako ang nag-suggest na magmulta ng five million dollars pag nag-positive ako sa drugs. Ako ang nagpa-insert nun,” he said.

FEATURED STORIES

The highly anticipated fight with Mayweather was scuttled five years ago due to conflicting demands on the drug test. Mayweather even accused Pacquiao of using performance enhancement drugs.

Pressed to confirm reports that the Mayweather fight is already a go, Pacquiao said the contract is “almost” finished.

Article continues after this advertisement

“Malapit na (matapos) ang negosasyon. Nag-agree na tayo sa terms and conditions. Hinihintay na lang natin yung part nila,” Pacquiao said.

“Mahirap magsalita nang tapos dahil napakaganda ng laban na yan… Kailangan matuloy ang laban na ito,” he added.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Floyd Mayweather Jr., Manny Pacquiao, News, Sports

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.